Company / Accounts Receivable
Jaguar Health, Inc. Accounts Receivable History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$1.5M
FY2025
5-year range
$1.5M / $2.1M
FY2021-FY2025
Trend
-0.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has declined for 3 consecutive years, from $2M in FY2020 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 10-year CAGR of +39.2%.
Declined from $2M to $2M over the past 3 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -6.8%
- 5-Year CAGR
- -6.2%
- 10-Year CAGR
- +39.2%
Key checks
Key Insights
- Jaguar Health, Inc.'s accounts receivable has declined for 3 consecutive years.
- 5-year CAGR of -6.2%, indicating a declining trend.
- In FY2025, accounts receivable decreased 0.4% year-over-year.
- Peak accounts receivable was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.5M | -0.4% |
| FY2024 | $1.5M | -18.7% |
| FY2022 | $1.9M | -10.4% |
| FY2020 | $2.1M | +24.0% |
| FY2019 | $1.7M | +69.9% |
| FY2018 | $995.7K | +112.9% |
| FY2017 | $467.7K | +9322.9% |
| FY2016 | $5.0K | -91.1% |
| FY2015 | $55.9K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026